XML 67 R53.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity (Details)
1 Months Ended 12 Months Ended
Aug. 15, 2025
USD ($)
Apr. 04, 2025
USD ($)
$ / shares
shares
Apr. 03, 2025
USD ($)
Aug. 16, 2024
USD ($)
Aug. 01, 2024
USD ($)
$ / shares
shares
Dec. 21, 2022
USD ($)
Apr. 30, 2025
$ / shares
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Jan. 05, 2024
USD ($)
Dec. 01, 2023
USD ($)
Jul. 24, 2023
USD ($)
Stockholders’ Equity [Line Items]                        
Common stock issued (in Shares) | shares               50,006,464 30,816,499      
Issuance costs               $ 20,000      
Maximum aggregate common stock offering price           $ 14,500,000       $ 9,300,000 $ 4,800,000 $ 2,600,000
Percentage of gross proceeds           3.00%            
Amount of common stock of sales agreement $ 6,750,000   $ 0 $ 3,000,000                
Aggregate offering price               9,614,037        
Issuance costs incurred               95,929 277,903      
Aggregate fair value               1,813,223      
Fair value change in warrant liability               (784,670) $ 327,092      
Higher floor price per share               $ 0.876        
Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Share issued (in Shares) | shares               18,755,899        
Aggregate offering price               $ 18,756        
PIPE Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Fair value change in warrant liability               784,670        
At The Market Offering [Member]                        
Stockholders’ Equity [Line Items]                        
Maximum aggregate common stock offering price               8,000,600        
Issuance costs incurred               608,558        
Financing cost               $ 9,325        
At The Market Offering [Member] | Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock issued (in Shares) | shares               5,544,489        
Share issued (in Shares) | shares               355,899 3,748,913      
Aggregate offering price               $ 414,037 $ 5,033,906      
Maximum [Member]                        
Stockholders’ Equity [Line Items]                        
Exercise price per share (in Dollars per share) | $ / shares                 $ 1.19      
Minimum [Member]                        
Stockholders’ Equity [Line Items]                        
Exercise price per share (in Dollars per share) | $ / shares             $ 0.465          
April 2025 Financing [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock issued (in Shares) | shares   16,000,000                    
Public per share (in Dollars per share) | $ / shares   $ 0.5                    
Underwriters exercisable days   45 days                    
Purchase of additional shares (in Shares) | shares   2,400,000                    
Issuance costs   $ 960,717                    
Commission percentage of underwriter   7.00%                    
Legal and other expenses   $ 316,717                    
Net proceeds   $ 8,239,283                    
August 2024 Private Placement [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock issued (in Shares) | shares         2,944,446              
Issuance costs         $ 200,000              
Warrants issued (in Shares) | shares         2,208,338              
Purchase price, per unit (in Dollars per share) | $ / shares         $ 0.9              
Exercise price per share (in Dollars per share) | $ / shares         $ 0.75   0.465 $ 1.19        
Gross proceeds         $ 2,650,000              
Aggregate fair value               $ 1,813,223        
August 2024 Private Placement [Member] | Risk-Free Interest Rate [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants and rights outstanding, measurement input               3.55 3.53      
August 2024 Private Placement [Member] | Expected Volatility [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants and rights outstanding, measurement input               94.5 115.7      
August 2024 Private Placement [Member] | Expected Life [Member                        
Stockholders’ Equity [Line Items]                        
Warrants and rights outstanding, measurement input               1.84 2.84      
August 2024 Private Placement [Member] | Expected Dividend Yield [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants and rights outstanding, measurement input               0 0      
PIPE Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Exercise price per share (in Dollars per share) | $ / shares             $ 0.876          
Aggregate shares issued (in Shares) | shares             20,834